Biotech

All Articles

Eli Lilly dives deeper in to AI with $409M Genetic Jump offer

.Eli Lilly has actually risen into an AI-enabled medicine discovery deal, partnering with RNA profes...

After FDA denial and also cutbacks, Lykos CEO is actually leaving behind

.Lykos CEO and also owner Amy Emerson is actually leaving, with main working police officer Michael ...

Novartis ignites new phase of Voyager contract along with $15M capsid offer

.Novartis levels a brand new frontier in its own partnership with Voyager Therapies, paying for $15 ...

Lilly blog posts even more favorable data on its own regular the hormone insulin possibility

.On the heels of an FDA being rejected for its own primary rivalrous Novo Nordisk, Eli Lilly is actu...

IN 8bio stops stage 2 trial, lays off fifty percent of labor force

.Merely a handful of months after dosing the initial person in a period 2 test for newly detected gl...

Lilly, Haya ink $1B biobuck being overweight treaty to explore dark genome

.Eli Lilly's look for excessive weight targets has led it to the dark genome. The Big Pharma has pro...

ArsenalBio increases $325M, rotates away from past lead property

.Toolbox Biosciences is actually carrying on up. The tissue treatment provider has added on $325 mil...

Lilly- backed weight loss biotech files IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...

Aelis' marijuana make use of medication fails period 2b, driving Indivior to review $100M possibility

.Aelis Farma's chances of protecting a quick, favorable decision on a $100 million alternative remit...

ProKidney standstills period 3 test not required for tissue treatment permission

.ProKidney has stopped some of a set of phase 3 trials for its own tissue treatment for renal ailmen...